CHICAGO – Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback